Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

P. Tsirigotis*, I. Danylesko, K. Gkirkas, N. Shem-Tov, R. Yerushalmi, M. Stamouli, A. Avigdor, A. Spyridonidis, J. Gauthier, G. Goldstein, J. Apostolidis, M. Mohty, A. Shimoni, A. Nagler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology